Imax Corp’s filing revealed that its Chief Financial Officer & EVP Fernandes Natasha unloaded Company’s shares for reported $75448.0 on Dec 09 ’24. In the deal valued at $25.52 per share,2,957 shares were sold. As a result of this transaction, Fernandes Natasha now holds 14,883 shares worth roughly $ 0.4 million.
Then, Weissman Kenneth Ian sold 6,309 shares, generating $160,927 in total proceeds. Upon selling the shares at $25.51, the Deputy GC, Corp. Sec. & CCO now owns 25,139 shares.
Before that, WELTON MARK sold 39,432 shares. Imax Corp shares valued at $1,005,741 were divested by the President, IMAX Theatres at a price of $25.51 per share. As a result of the transaction, WELTON MARK now holds 111,315 shares, worth roughly $3.01 million.
Seaport Research Partners initiated its Imax Corp [IMAX] rating to a Buy in a research note published on July 24, 2024; the price target was $23. A number of analysts have revised their coverage, including Barrington Research’s analysts, who remained covering the stock and in late April has reiterated a ‘”an Outperform”‘ rating for it. B. Riley Securities also remained covering IMAX and reiterated its “Buy” recommendation on December 05, 2022. B. Riley Securities maintained its rating on October 12, 2022. It rated IMAX as “a Buy”.
Price Performance Review of IMAX
On Tuesday, Imax Corp [NYSE:IMAX] saw its stock jump 0.19% to $27.02. Over the last five days, the stock has gained 6.13%. Imax Corp shares have risen nearly 5.55% since the year began. Nevertheless, the stocks have risen 85.07% over the past one year. While a 52-week high of $27.29 was reached on 02/18/25, a 52-week low of $14.48 was recorded on 01/16/25. SMA at 50 days reached $24.69, while 200 days put it at $20.96.
Levels Of Support And Resistance For IMAX Stock
The 24-hour chart illustrates a support level at 26.76, which if violated will result in even more drops to 26.50. On the upside, there is a resistance level at 27.33. A further resistance level may holdings at 27.64. The Relative Strength Index (RSI) on the 14-day chart is 76.32, which indicates overbought technical sentiment, while the Moving Average Convergence Divergence (MACD) stands at 1.76, which suggests price will go up in the next trading period. Percent R suggests that price movement has been bullish at 8.47%. Stochastics %K at 92.07% indicates the stock is a selling.
The most recent change occurred on May 24, 2022 when Rosenblatt began covering the stock and recommended ‘”a Buy”‘ rating along with a $25 price target.